Ventyx Biosciences Inc.

1.48
-0.10 (-6.33%)
At close: Mar 03, 2025, 11:30 AM

Ventyx Biosciences Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 941K 470K 30K n/a n/a
Gross Profit n/a -941K -470K -30K n/a n/a
Operating Income -148.45M -207.99M -113.14M -67.15M -7.05M -4.18M
Interest Income -13.42M 15.07M 4.67M 78K 358.00 146.00
Pretax Income -135.12M -192.96M -108.43M -83.75M -28.17M -4.33M
Net Income -135.12M -192.96M -107.96M -78.37M -28.53M -4.47M
Selling & General & Admin 31.45M 32.23M 25.4M 8.67M 684K 628K
Research & Development 117M 175.77M 87.74M 58.48M 6.37M 3.55M
Other Expenses n/a 0.00 41K -5.45M -1K -1K
Operating Expenses 148.45M 207.99M 113.14M 67.15M 7.05M 4.18M
Interest Expense n/a n/a n/a 99K 358K 146K
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 207.99M 113.14M 67.15M 7.05M 4.18M
Income Tax n/a n/a -470K -5.38M 358K 146K
Shares Outstanding (Basic) 68.48M 58.54M 52.47M 50.41M 50.3M 50.3M
Shares Outstanding (Diluted) 68.48M 58.54M 52.47M 50.41M 50.3M 50.3M
EPS (Basic) -1.97 -3.3 -2.06 -1.55 -0.57 -0.09
EPS (Diluted) -1.97 -3.3 -2.06 -1.55 -0.57 -0.09
EBITDA -148.45M -207.84M -107.96M -67.12M n/a -1K
Depreciation & Amortization n/a 158K 470K 30K 7.05M 4.18M